Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026
← All news
Markets

Nektar Therapeutics chief R&D officer Zalevsky sells $13,388 in shares

1 source ·2 articles ·Aug 21, 05:18 UTC Nektar Therapeutics

Covered by 1 outlet

Investing 2

All coverage · 2 articles

Investing.com Canada ·Aug 21, 05:18 UTC

Nektar Therapeutics chief R&D officer Zalevsky sells $13,388 in shares

Investing.com UK ·Aug 21, 05:18 UTC

Nektar Therapeutics chief R&D officer Zalevsky sells $13,388 in shares